The panel brings together experts in AI policy and regulation to explore the current landscape, what can we learn from other multinational attempts at regulation, the likely impact of GDPR, and more.
Alison leads the Humanities work at the PHG Foundation, a health policy think tank which is part of University of Cambridge. Her research focuses on the regulation and governance of genomic data for clinical care and research, the impact of automated processing and artificial intelligence on existing legal and ethical frameworks, and the challenges and opportunities associated with delivering personalised healthcare. Alison has professional qualifications in law and nursing and a masters qualification in healthcare ethics.
Andrea Renda is an Italian social scientist, whose research lies at the crossroads between economics, law, technology and public policy. He is Senior Research Fellow and Head of Global Governance, Regulation, Innovation and the Digital Economy at the Centre for European Policy Studies (CEPS). From September 2017, he holds the Chair for Digital Innovation at the College of Europe in Bruges (Belgium) where he has also leading the course “Regulatory Impact Assessment for Business” since 2007. He is also a non-resident fellow at Duke University's Kenan Institute for Ethics. Over the past two decades, he has provided academic advice to several institutions, including the European Commission, the European Parliament, the OECD, the World Bank and several national governments around the world. An expert in technology policy and better regulation, he is a member of the ESIR (Economic and Social Impacts of Research) expert group of the European Commission; and a member of the EU Blockchain Observatory and Forum. He is also a member of the Editorial Board of the international peer-reviewed journals “Telecommunication Policy” (Elsevier) and of the European Journal of Risk Regulation (Lexxion); a member of the Scientific Board of the International Telecommunications Society (ITS) and Chair of the Scientific Board of European Communications Policy Research (EuroCPR). He holds a Ph.D. degree in Law and Economics awarded by the Erasmus University of Rotterdam.
Loubna Bouarfa is a machine learning scientist turned entrepreneur.
In 2016, after several years in academia, Loubna founded her own artificial intelligence company: OKRA Technologies. OKRA is a data analysis platform, using deep machine learning algorithms to transform complex datasets into evidence-based predictions, in real time. The platform was designed to equip Healthcare and Life Sciences professionals with the foresight to improve patient outcomes.
Before OKRA, Loubna spent over 10 years validating and implementing machine learning (ML) solutions for real-world applications, such as an autonomous ML system that tracks surgeons’ operating movements and prevents error in real time.
Loubna has won several awards and was recognised as a leading innovator by the MIT Technology Review in 2017.
Beyond her business, Loubna has recently been appointed by the European Commission as a High-Level Expert on Artificial Intelligence. She will support the EU by developing recommendations on ethical, legal and societal issues related to AI, impacting the health, safety and freedom of the wider society.
On a personal level, Loubna is a strong advocate for diversity and challenging the status quo. Having lived in Morocco, moving to the Netherlands at the age of 17, and later to the UK with a young family, she realised the power of remaining outside her comfort zone.
Jade is a researcher with the Governance of Artificial Intelligence Program (GovAI) at the Future of Humanity Institute (University of Oxford). Her research focuses on the governance of emerging dual-use technologies, with a specific focus on firm-government relations in the US and China with respect to advanced artificial intelligence. Jade has a background in engineering, international law, and policy design and evaluation.
Dr Matthew Fenech is an artificial intelligence policy consultant, with expertise in developing and advocating for policies that maximise the opportunities and minimise the risks of these technologies. His main interest is in the ethics and practicalities of the use of AI in healthcare, a field to which he brings his 10 years of experience working as a hospital doctor and clinical academic. He has also authored reports about AI and other emerging technologies in low- & middle-income countries, and on the impact of automation on the future of work. He regularly speaks about these topics in lectures and in the media.